C92.A

Applicable To

• Acute myeloid leukemia with dysplasia of remaining hematopoesis and/or myelodysplastic disease in its history

Clinical Information

• An acute myeloid leukemia arising de novo and not as a result of treatment. It is characterized by the presence of myelodysplastic features in at least 50% of the cells of at least two hematopoietic cell lines. Patients often present with severe cytopenia.

• An acute myeloid leukemia, characterized by the presence of myelodysplastic features in at least 50% of the cells of at least two hematopoietic cell lines, arising de novo and not as a result of treatment.

Details

• C92.A should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.

• The 2023 edition of ICD-10-CM C92.A became effective on October 1, 2022.

• This is the American ICD-10-CM version of C92.A – other international versions of ICD-10 C92.A may differ.